Sundström Anna E, Nordin Maria, Nordin Steven, Neely Anna Stigsdotter, Gavelin Hanna Malmberg
Department of Psychology, Umeå University, Umeå, Sweden.
Department of Health, Education and Technology, Luleå University of Technology, Lulea, Sweden.
Stress Health. 2025 Feb;41(1):e70001. doi: 10.1002/smi.70001.
The Shirom-Melamed Burnout Questionnaire/Measure (SMBQ/SMBM) is a self-report instrument frequently used for assessing degree of burnout and screening for stress-related exhaustion disorder. The aim of the present study was three-fold. First, to examine reliability and construct validity of different versions of SMBM with 6-22 items in a clinical context. Second, to examine the criterion validity by assessing sensitivity and specificity and determining clinical cut-offs for these versions of the SMBM, and third to examine the prevalence of burnout in a general population and primary care sample using the proposed cut-offs. Two Swedish samples were used for the first two purposes: a clinical sample of patients diagnosed with exhaustion disorder (n = 149), and a matched sample of healthy controls (n = 60). For the third purpose a sample from the general population (n = 3406), and a primary care clinical sample (n = 326) was used. The modified versions of the SMBM showed good internal consistency, construct validity, dimensionality and model fit on the clinical exhaustion disorder sample, as well as configural measurement invariance across clinical and non-clinical samples. The sensitivity (94.6%-95.3%) and specificity (93.3%-95.0%) in identifying cases with exhaustion disorder based on the cut-off of 4.0 for the 19-, 16- and 11-items versions, and on the cut-off of 3.75 for the 6-item version was high. The prevalence of burnout was 81.2% in the primary care sample and 16.6% in the general population sample. The findings indicate that the SMBM is a useful instrument for screening for exhaustion disorder and burnout.
希罗-梅拉梅德倦怠问卷/量表(SMBQ/SMBM)是一种自我报告工具,常用于评估倦怠程度并筛查与压力相关的疲惫障碍。本研究的目的有三个。首先,在临床环境中检验包含6 - 22个条目的不同版本SMBM的信度和结构效度。其次,通过评估敏感性和特异性并确定这些版本SMBM的临床临界值来检验效标效度,第三,使用提议的临界值检验普通人群和初级保健样本中倦怠的患病率。前两个目的使用了两个瑞典样本:一个被诊断为疲惫障碍的患者临床样本(n = 149),以及一个匹配的健康对照样本(n = 60)。为实现第三个目的,使用了一个普通人群样本(n = 3406)和一个初级保健临床样本(n = 326)。SMBM的修订版本在临床疲惫障碍样本上显示出良好的内部一致性、结构效度、维度性和模型拟合度,以及临床和非临床样本间的构型测量不变性。基于19项、16项和11项版本4.0的临界值以及6项版本3.75的临界值来识别疲惫障碍病例时,敏感性(94.6% - 95.3%)和特异性(93.3% - 95.0%)都很高。初级保健样本中倦怠的患病率为81.2%,普通人群样本中为16.6%。研究结果表明,SMBM是筛查疲惫障碍和倦怠的有用工具。